Cas:135381-77-0 4-[(4-fluorophenyl)methyl]-2-[1-(2-phenylethyl)azepan-4-yl]phthalazin-1-one manufacturer & supplier

Chemical Name:4-[(4-fluorophenyl)methyl]-2-[1-(2-phenylethyl)azepan-4-yl]phthalazin-1-one

CAS.NO:135381-77-0

Synonyms:flezelastine[inn];Flezelastine;4-[(4-fluorophenyl)methyl]-2-(1-phenethylazepan-4-yl)phthalazin-1-one

Molecular Formula:C₂₉H₃₀FN₃O

Molecular Weight:455.56600

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:606.7ºC at 760mmHg

Density:1.18g/cm3

Index of Refraction:1.623

PSA:38.13000

Exact Mass:455.23700

LogP:5.33400

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like flezelastine[inn] chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-[(4-fluorophenyl)methyl]-2-(1-phenethylazepan-4-yl)phthalazin-1-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,flezelastine[inn] Use and application,flezelastine[inn] technical grade,usp/ep/jp grade.

Related News: Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry. 4-[(4-fluorophenyl)methyl]-2-[1-(2-phenylethyl)azepan-4-yl]phthalazin-1-one manufacturer Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs. 4-[(4-fluorophenyl)methyl]-2-[1-(2-phenylethyl)azepan-4-yl]phthalazin-1-one supplier The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth. 4-[(4-fluorophenyl)methyl]-2-[1-(2-phenylethyl)azepan-4-yl]phthalazin-1-one vendor From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats. 4-[(4-fluorophenyl)methyl]-2-[1-(2-phenylethyl)azepan-4-yl]phthalazin-1-one factory Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry.